Stephanie Wang drafts and prosecutes patent applications that span the electrical, chemical, biotech and mechanical industries. Stephanie’s technical background enables her to prepare and prosecute patent applications directed to diverse technologies including solar cell design, fabrication, packaging and assembly; semiconductor and network-related technologies including software; renewable energy, nanotechnology, mechanical and medical devices; bioinformatics applications based on DNA microarray technologies; protein design based on gene synthesis; RNAi-based technologies; and applications based on genetic, chemical or immunological therapies. Stephanie has practiced on issues in nearly all stages of patent prosecution, from conducting inventor interview, drafting and filing national and international applications, responding to office action at various stages, to filing appeal briefs and reply briefs in the appeal proceedings. She manages patent portfolios and works with inventors and in-house counsels to identify patentable inventions; provides advice on patentability, freedom-to-operate, infringement and validity matters; and monitors and analyzes competition intellectual property for investment and acquisition purposes. Stephanie has also provided technical support to litigation cases and worked with expert witnesses.

Prior to joining Squire Sanders, Stephanie practiced patent law at two international law firms in San Francisco, first as a patent agent and then as an associate. Stephanie has an undergraduate degree in chemistry, a Ph.D. degree in chemistry and chemical biology with a focus in protein X-ray crystallography. Stephanie was also an American Heart Association postdoctoral fellow at the Sandler Center for Basic Research in Parasitic Diseases at the University of California, San Francisco. In this position, she determined the x-ray structures of two novel proteins, a major hemoglobin-digesting enzyme for the malaria parasite Plasmodium falciparum and a virulence factor for the heart-disease-causing parasite Trypanosoma cruzi.

Since 2002, Stephanie has been a volunteer for Shin Shin Educational Foundation to help build elementary schools in rural China.

Representative Experience

• Representing clients in matters involving freedom-to-operate analysis of butadiene extraction method and system.
• Representing clients in matters relating to drug delivery systems and implantable medical devices.
• Drafting and prosecuting patent applications under the Accelerated Examination procedures at the US Patent and Trademark Office. 

Publications

• Co-author, “Chinese Patent-Law and Implementation Amendments Bring Key Changes, Interpretive Challenges,” Intellectual Property & Technology Law Journal 23 (5), pp. 17-22, 2011.
• First-author, “The Structure of Chagasin in Complex with a Cysteine Protease Clarifies the Binding Mode and Evolution of an Inhibitor Family,” Structure 15, pp. 535-543, 2007.
• First-author, “Structural Basis for Unique Mechanisms of Folding and Hemoglobin Binding by a Malarial Protease,” Proc Natl Acad Sci USA 103, pp. 11503-11508, 2006.
• Co-author, “A Unique Fold Mediates Interactions Between Malarial Protease Falcipain 2 and its Natural Substrate Hemoglobin,” Proc Natl Acad Sci USA 102, pp. 9138-9143, 2005.
• First-author, “The Extended Interactions and Gla Domain of Blood Coagulation Factor Xa,” Biochemistry 42: pp. 7959-7966, 2003.
• First-author, “Crystal Structure of Thrombin-Ecotin Reveals Conformational Changes and Extended Interactions,” Biochemistry 40, pp. 10038-10046, 2001.
• Co-author, “The Role of Ecotin Dimerization in Protease Inhibition,” Journal of Molecular Biology 308, pp. 975-991, 2001.